| Minocycline Hydrochloride | Medicis (Valeant) | ||
| 45,65,90,115,135 mg; Tablet ER |
Less Than $1000 mn
|
||
|
Less Than 5
|
More Than 5
|
||
|
Less Than 5
|
None | ||
|
More Than 5
|
More Than 5
|
||
| None | |||
|
No
| |||
| Solodyn | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 |
|---|---|---|---|---|---|---|
| ***** | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* |
| **** (****) | ******* | ******* | ******* | ******* | ******* | ******* |
| ***** | ******* | ******* | ******* | ******* | ******* | ******* |
| Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
|---|---|---|---|---|---|
| ***** | *** \ ** | *** ********* | *** ********* | ******** ************ | *** ** ****** |
| **** (****) | ** \ ** | **** **, **** | ******* | ******** | ** **** ******** ** ***** **, **** |
| ***** | ** \ ** | **** **, **** | ******* | ******** | ******** ** **** **, **** |
| Minocycline Hydrochloride | Medicis (Valeant) | ||
| 80mg, 105mg; Tablet ER |
Less Than $1000 mn
|
||
|
Less Than 5
|
More Than 5
|
||
|
Less Than 5
|
None | ||
|
More Than 5
|
Less Than 5
|
||
| Indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. | |||
|
Yes
| |||
| Solodyn | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 |
|---|---|---|---|---|---|
| *** (*******) | ******* | ******* | ******* | ******* | ******* |
| ********* | ******* | ******* | ******* | ******* | ******* |
| ***** | ******* | ******* | ******* | ******* | ******* |
| Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
|---|---|---|---|---|---|
| *** (*******) | *** \ ** | *** **, **** | ******* | ******** | *** ****** *** **** |
| ********* | ** \ ** | *** *, **** | ******* | ******** | ******** ** *** * |
| ***** | ** \ ** | *** **, **** | ******* | **** | ****** **** ******** |
| Minocycline Hydrochloride | Medicis (Valeant) | ||
| 55mg; Tablet, Extended release |
Less Than $1000 mn
|
||
|
Less Than 5
|
More Than 5
|
||
| None |
Less Than 5
|
||
|
Less Than 5
|
Less Than 5
|
||
| Indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. | |||
|
Yes
| |||
| Solodyn | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 |
|---|---|---|---|---|---|---|
| ***** | ******* | ******* | *** ********* | *** ********* | ******* | *** ********* |
| ********* | ******* | ******* | *** ********* | *** ********* | *** ********* | *** ********* |
| ***** | ******* | ******* | *** ********* | *** ********* | *** ********* | *** ********* |
| Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
|---|---|---|---|---|---|
| ***** | ** \ ** | ** | ******* | ******** | ******** ** *** **, **** |
| ********* | ** \ ** | *** **, **** | ******* | ******** | ******** ** *** **, **** |
| ***** | *** \ *** | *** **, **** | ******* | ******** | ******** ** *** **, **** |
Download ParaIV Report